Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Studies add new findings to breast cancer therapy body of knowledge
February 16th, 2006
New findings from Belgium, Italy and the United Kingdom; michael@mbaum describe advances in breast cancer therapy. Study 1: Aromatase inhibitors provide improved efficacy compared to tamoxifen in the adjuvant setting. "Approximately three-quarters of all invasive breast tumors are estrogen and/or progesterone receptor-positive. The selective estrogen receptor modulator tamoxifen has been the preferred endocrine therapy for almost four decades," investigators in Belgium report. "One of the most significant advances in endocrine therapy for women after menopause with early breast cancer is the introduction of third-generation...
Source: Women's Health Weekly (2006-02-16)
|
